• Adobe: Goldman Sachs continues to buy. Price target raised to $550.
  • American Express: Citigroup still short. Price target down to $148 from $150.
  • Atlanticus: Jefferies initiated coverage with a recommendation of buy. PT upgrades 16% to $50.
  • Bio-Rad Laboratories: Wells Fargo Securities reinstated coverage with a recommendation of overweight. PT up 45% to $550.
  • Carnival: Citi raised the target to $18 from $14. Maintains buy rating.
  • Informa: HSBC remains Buy with price target raised from £7300 to £8800.
  • Mears Group: Peel Hunt cut the recommendation to add from buy. Price target set to 275 pence.
  • MorphoSys: Wells Fargo set price target to $17, with a recommendation of buy.
  • Neogen: Wells Fargo Securities initiated coverage with a recommendation of overweight. PT set to $22.
  • RPC: Citi cut the recommendation to sell from neutral. PT down 10% to $7.
  • Wells Fargo: Piper Sandler neutral on the company. Price target revised upwards from $41 to $43.